Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Researchers found that heart risks begin to rise again within six months after stopping GLP-1 medications, and much of the ...

GLP-1 drugs can suppress thirst cues, leading to dehydration exacerbated by side effects like nausea and diarrhea. There's an ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other ...

Experimenters hope to harness the powerful effects of medications such as Ozempic and Wegovy at doses smaller than those studied most.

A 2026 informational evaluation of MEDVi's GLP-1 weight loss program structure, compounded semaglutide and branded Ozempic ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

Cost not primary barrier to GLP-1 use, Axios-Ipsos survey shows preference for diet and exercise limits adoption despite rising drug use.

In the latest season of "The Secret Lives of Mormon Wives," Layla Taylor reveals that she's begun using GLP-1s despite having no medical need for them. Experts highlight the risk of the drugs for ...

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...